January/February 2022
Biopharma Asia
January/February 2022 | Volume 11 Issue 1
Rapid Methods the Next Phase: A Framework for Multi-Product Adoption of Rapid Sterility Te...
Miriam Guest, Associate Principal Microbiologist, New Modalities and Parenteral Developmen...
Holistic Approach to the Industry 4.0 Investment Breaking Down the Fences Between R&D...
Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning, The Janssen Pharm...
Bringing PAT into the Mix for High-Quality Solid Dosage Manufacturing
Martin Gadsby, Owner, Optimal Industrial Automation Ltd
Employing HME As a Cost Effective Method of Increasing Solubility of Water Insoluble APIs
Dennis Douroumis, Professor in Pharmaceutical Technology and Process Engineering; Director...
pH Stability Prediction of a Pharmaceutical Formulation Using a Chemometric Hard Modeling ...
Husheng Yang, Senior Scientific Investigator, Chemometrician, GlaxoSmithKline Kirk Lewis,T...
Trends in Single-Use Mixing Technologies for Biomanufacturing With an Insight Into Lonza I...
Pall Corporation
















